Cord Blood America (CBAI.OB) is focused on becoming the most respected stem cell preservation company in the world, and after its Thursday volume of over 700,000 shares, many people would argue that they are on the right track. The company plans to achieve its goal by educating expectant parents, families with a history of disease, critically ill patients, and all others who wish to learn about their life saving service.
Through its subsidiary, CorCell, the company is a licensed and accredited cord blood company, which has been dedicated to its work since 1995. The company began in Pennsylvania as the first private cord Blood Company licensed for umbilical cord blood collection and today is one of the leaders in the industry.
Cord Blood America has been featured on MoneyTV, the financial television program. This television station has taken special interest in the Company, featuring Cord Blood America many times in the past, and broadcasted to 45 million homes in Western Europe and 75 million homes in the U.S.
Cord Blood reported back in November that revenues increased 121% for the nine months ended November 30, 2007 compared to the same period in 2006. Matthew Schissler, CEO of Cord Blood America, commented on the results, “The significant increase in revenue is partially due to the accrete acquisitions Cord Blood America has made, which increased the number of umbilical cord samples, and increased marketing efforts.”
Cord Blood America is focused on storing umbilical cord blood stem cells, which may be used later to cure a growing number of diseases including cancer, leukemia, blood, and immune disorders. The Company’s goal is to become the most respected stem cell preservation company in the industry and has made positive steps forward to achieving its initiative.
While Semotus Solutions’ CEO gave an update on the company’s AMEX listing and the Green Baron Report Editor-in-Chief provided an outlook into what the stock markets may do in 2008, Mr. Schissler, discussed recent funding and his strategy for future acquisitions.
Through its companies, Cord Blood America provides Cord and Placenta blood preservation. They are also actively involved in educating expectant parents and families with a history of severe illnesses. The three companies they operate through are CorCell, Cord Partners Blood Banking, and their educational advertising company, Rainmakers Int.
Obstetricians for safe, simple and uncomplicated methods prefer their stem-cell harvesting procedures. The precious stem cells are stored in its private laboratory, which is both internationally known, and AABB accredited.
Cord Blood America has demonstrated its desire to increase shareholder value and become cash flow positive by retiring registered convertible debt, in addition to lowering operational loss, increasing revenues, and halving the basic and diluted loss per share.
Let us hear your thoughts: Cord Blood America Inc. Message Board